Literature DB >> 9227440

Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity.

P P Jones1, K P Davy, S Alexander, D R Seals.   

Abstract

Tonic sympathetic nerve activity (SNA) increases with age, but the mechanisms are unknown. There is evidence that SNA is positively related to total and abdominal body fat, which also increase with age. We tested the hypotheses that 1) the elevation in SNA with age is partially accounted for by higher abdominal and/or total body fat and 2) skeletal muscle is a target of the adiposity-related sympathetic effects. Direct microneurographic recordings of skeletal muscle SNA (MSNA) were obtained during supine rest in 16 older (64 +/- 1 yr, means +/- SE) and 16 young (24 +/- 1 yr) adult males. Central body fat was estimated by waist circumference (WC) and fat mass (FM) by hydrostatic weight. MSNA, WC, and FM were higher in the older vs. young males (44 +/- 2 vs. 22 +/- 2 bursts/min, 91 +/- 2 vs. 79 +/- 1 cm, and 19 +/- 2 vs. 9 +/- 1 kg, respectively; all P < 0.0001). Although univariate correlations were high for MSNA and both WC (r = 0.77) and FM (r = 0.75), stepwise multiple regression analysis revealed WC to be the best predictor of MSNA (R2 = 0.60, P < 0.0001), with FM explaining only an additional 2% of the variance (not significant). Statistically covarying for WC reduced but did not eliminate the difference in adjusted age-group means for MSNA (39 +/- 3 vs. 26 +/- 2 bursts/min, P = 0.003). We conclude that 1) the elevated SNA in older adults is partially related to higher body fat, particularly in the abdominal region, and 2) skeletal muscle is a target of the adiposity-related sympathetic effects observed with aging.

Mesh:

Year:  1997        PMID: 9227440     DOI: 10.1152/ajpendo.1997.272.6.E976

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

Review 1.  Obesity and autonomic function.

Authors:  S D Beske; J A Taylor
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 2.  Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors:  Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal:  Geroscience       Date:  2018-12-05       Impact factor: 7.713

3.  Obesity and catecholamine responses to maximal exercise in adolescent girls.

Authors:  H Zouhal; G Jabbour; H Youssef; A Flaa; E Moussa; C Groussard; C Jacob
Journal:  Eur J Appl Physiol       Date:  2010-05-08       Impact factor: 3.078

4.  Acute sex hormone suppression reduces skeletal muscle sympathetic nerve activity.

Authors:  Danielle S Day; Wendolyn S Gozansky; Christopher Bell; Wendy M Kohrt
Journal:  Clin Auton Res       Date:  2011-06-03       Impact factor: 4.435

Review 5.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

6.  Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men.

Authors:  Sean A Martin; Matthew T Haren; Villis R Marshall; Kylie Lange; Gary A Wittert
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

Review 7.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 8.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

Review 9.  Catecholamines and obesity: effects of exercise and training.

Authors:  Hassane Zouhal; Sophie Lemoine-Morel; Marie-Eve Mathieu; Gretchen A Casazza; Georges Jabbour
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

10.  Influences of gender on the interaction between sympathetic nerve traffic and central adiposity.

Authors:  Jens Tank; Karsten Heusser; Andre Diedrich; Dagmara Hering; Friedrich C Luft; Andreas Busjahn; Krzysztof Narkiewicz; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.